FUCHS SE/ DE000A3E5D64 /
| 2024-04-18 11:19:38 AM | Chg. -0.37 | Volume | Bid11:19:47 AM | Ask11:20:24 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 44.46EUR | -0.83% | 9,781 Turnover: 157,125.44 |
44.44Bid Size: 52 | 44.46Ask Size: 107 | 5.33 bill.EUR | 2.49% | 21.39 |
GlobeNewswire
04-10
BPM Partners and BARC Join Forces to Deliver First of Its Kind Global CPM Priorities and Trends Rese...
GlobeNewswire
03-19
Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full...
GlobeNewswire
03-12
Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive...
GlobeNewswire
03-07
American Institutes for Research Education Experts to Present at the Council for Exceptional Childre...
GlobeNewswire
01-30
PolTREG CEO Trzonkowski co-authors peer-reviewed article showing scientific progress in T-reg autoim...
GlobeNewswire
01-24
Fordham University Gabelli School of Business Global Healthcare Innovation Management Center to Host...
GlobeNewswire
2023-12-09
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...
GlobeNewswire
2023-11-13
Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portf...
GlobeNewswire
2023-11-06
Sermonix Pharmaceuticals Announces JCO Precision Oncology Publication of Case Report on a Complete R...
GlobeNewswire
2023-10-19
CIO Leadership: The Visionary Leadership Needed to Drive an Enterprise Generative AI Strategy will P...
GlobeNewswire
2023-09-25
L.B. Foster and FUCHS Extend Strategic Partnership with Industry-Leading Friction Management Product...
GlobeNewswire
2023-09-06
OTC Markets Group Announces Expanded Relationship with Moomoo Financial Inc.
